MAD1 peptide was synthesized as described previously.[9 (link)] In brief, Fmoc-based solid-phase peptide synthesis was performed on Rink Amide ProTide Resin using CEM Liberty Blue Automated Microwave Peptide Synthesizer. Fluorescent labeling of MAD1 using NHS-Fluorescein (FITC-MAD1) was performed as previously described.[31 (link)] Next, peptide cleavage and deprotection was performed by stirring in TFA:thioanisole:1,2-ethanedithiol:anisole (90:5:3:2 ratio) solution under argon for 3 hours at 40°C. Peptides were purified by reverse-phase HPLC (Shimadzu; Columbia, MD) using a Phenomenex Luna Omega PS C18 column (Torrance, CA) with a linear 1%/min. solvent gradient of solvent A (0.1% TFA) and solvent B (0.1% TFA in 90% acetonitrile). Purity of MAD1 peptide was confirmed by reverse-phase HPLC-MS (Figure S9). Purified MAD1 was lyophilized and stored at −20 °C before use.